A Landmark Estée Lauder Brand Sale Takes Shape
Estée Lauder Companies is nearing a pivotal portfolio shake-up as it reportedly receives final bids for Too Faced, Smashbox and Dr. Jart+. The Estée Lauder brand sale process, first floated in early 2026, has evolved from a single package offer to a more flexible structure: bidders can now pursue the two colour brands together or target Dr. Jart+ separately. According to reports, at least one party is evaluating all three assets, while others are focused either on the makeup duo or on Dr. Jart+ alone. Estée Lauder has declined to comment, but the move aligns with management’s previously stated intention to review underperforming brands and streamline operations. Too Faced and Dr. Jart+ were both flagged as laggards in recent results, underscoring how portfolio pruning, rather than constant expansion, is increasingly central to beauty industry consolidation strategies.
Dr. Jart+ Ownership Change and the Return of Local Control
Among the three assets, Dr. Jart+ stands out as a case study in how brand ownership can influence performance. Private equity firm PTA Partners is reportedly exploring a joint acquisition of Have & Be, the company behind Dr. Jart+, in a move that would reverse its previous transfer to an American beauty conglomerate and reconnect the label with its original ecosystem. Since Estée Lauder acquired full control of Dr. Jart+, the brand has struggled, with revenue dropping sharply and turning from profit to loss. Industry observers argue that the group failed to keep pace with fast-moving beauty trends and weakened local marketing capabilities. PTA Partners, backed by domestic strategic investors, believes a Dr. Jart+ ownership change could unlock value by leveraging advanced manufacturing, influencer-driven promotion and sustained global interest in its skincare innovation. This highlights how beauty mergers and acquisitions are no longer one-way flows into big Western groups.

Founder Power: Charlotte Tilbury Reshapes Deal Terms
While Estée Lauder trims its portfolio, its exploratory merger talks with Puig illustrate another disruptive force: founder leverage. Charlotte Tilbury, who retains a minority stake in her namesake brand, is reportedly seeking to renegotiate the terms of Puig’s staged buyout. The existing agreement includes earn-outs and performance incentives, as well as a change-of-control clause that may allow Tilbury to force a sale of her stake if Puig merges with another giant. Such a move could trigger a large additional payment obligation that Estée Lauder would be reluctant to inherit, complicating merger modelling. This episode underscores how modern beauty mergers and acquisitions must navigate complex founder agreements, contingent payouts and brand equity tied closely to a personality. In an era when star founders often front their brands, their contractual rights can materially shape whether mega-deals proceed at all.

Financial Pressures Driving Beauty Industry Consolidation
Estée Lauder’s divestment drive is unfolding against the backdrop of broader financial pressure on legacy beauty conglomerates. The company is in the second year of its Profit Recovery and Growth Plan, which targets cost cuts through service consolidation, increased outsourcing and substantial workforce reductions. At the same time, it has reportedly enlisted J.P. Morgan to arrange around €5 billion in financing to support a potential combination with Puig, a transaction speculated to create a group valued at about USD 40 billion (approx. RM184 billion). Together, these moves reveal how slowing sales, shifting consumer habits and geopolitical uncertainty are pushing large players toward both aggressive restructuring and scale-building deals. The Estée Lauder brand sale of Too Faced, Smashbox and Dr. Jart+ is less an isolated event than a symptom of an industry where size, focus and balance sheet strength are becoming critical competitive weapons.
What the Coming Ownership Shake-Up Means for the Market
With final bids in and a decision expected within weeks, the outcome of a potential Too Faced acquisition, the sale of Smashbox and a Dr. Jart+ ownership change could redraw the beauty landscape. Buyers of the colour brands may seek to revitalise them via fresher positioning, faster product cycles and more digitally native marketing. A new owner for Dr. Jart+ would likely prioritise regional innovation pipelines and cross-border e-commerce, tapping into demand for advanced skincare formats. For Estée Lauder, offloading underperformers frees capital and management attention for core franchises and any future tie-up with Puig. More broadly, this moment crystallises a shift from the old model of endless brand accumulation to a sharper, more financially disciplined era of beauty industry consolidation, in which portfolios are continuously traded, resized and optimised for growth and resilience.
